Readystate Asset Management »

Arrowhead Pharmaceuticals In Note 1/1 shares owned by Readystate Asset Management

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals In Note 1/1 shares owned by Readystate Asset Management from 13F filings

Historical chart of Readystate Asset Management investment in Arrowhead Pharmaceuticals In Note 1/1

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals In Note 1/1 held by Readystate Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals In Note 1/1 by Readystate Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $26M 25M 1.04

More positions owned by Readystate Asset Management

Rivian Automotive Note 3.625%10/1 (Principal)
Mirum Pharmaceuticals Note 4.000% 5/0 (Principal)
Norfolk Southern (NSC)
Granite Constr Note 3.750% 5/1 (Principal)
Warner Bros Discovery Com Ser A (WBD)
Transmedics Group Note 1.500% 6/0 (Principal)
Lantheus Hldgs Note 2.625%12/1 (Principal)
Bentley Sys Note 0.375% 7/0 (Principal)
Century Alum Note 2.750% 5/0 (Principal)
Centrus Energy Corp Note 2.250%11/0 (Principal)
Meta Platforms Cl A (META)
Soleno Therapeutics (SLNO)
Freshpet Note 3.000% 4/0 (Principal)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)

View all positions for Readystate Asset Management

Top funds holding Arrowhead Pharmaceuticals In Note 1/1

Deerfield Management Company
Camden Asset Management
LMR Partners
Readystate Asset Management
Calamos Advisors
Context Capital Management
Bnp Paribas Arbitrage, Snc
Oaktree Capital Management
Polar Securities
Lazard Asset Management
Shenkman Capital Management
Point72 Asset Management
SSI Investment Management
Ing Investment Management
UBS Group

View all funds holding Arrowhead Pharmaceuticals In Note 1/1